カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

避妊経皮パッチの世界市場2022：プロゲスチン単独避妊薬、複合ホルモン避妊薬

◆英語タイトル：Global Contraceptive Transdermal Patche Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO19244 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：105 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

避妊経皮パッチ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の避妊経皮パッチの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

避妊経皮パッチ市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・プロゲスチン単独避妊薬、複合ホルモン避妊薬

用途別セグメントは次のように区分されます。
・病院、家庭、診療所

世界の避妊経皮パッチ市場の主要な市場プレーヤーは以下のとおりです。
・Mylan Nv、Ansell Limited、Bayer AG、Church & Dwight Co., Inc.、Merck & Co., Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Limited、The Cooper Companies, Inc.、The Female Health Company、Abviee Inc

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、避妊経皮パッチ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な避妊経皮パッチメーカーの企業概要、2019年～2022年までの避妊経皮パッチの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な避妊経皮パッチメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別避妊経皮パッチの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの避妊経皮パッチの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での避妊経皮パッチ市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および避妊経皮パッチの産業チェーンを掲載しています。
・第13、14、15章では、避妊経皮パッチの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 避妊経皮パッチの概要
- 種類別分析（2017年vs2021年vs2028年）：プロゲスチン単独避妊薬、複合ホルモン避妊薬
- 用途別分析（2017年vs2021年vs2028年）：病院、家庭、診療所
- 世界の避妊経皮パッチ市場規模・予測
- 世界の避妊経皮パッチ生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Mylan Nv、Ansell Limited、Bayer AG、Church & Dwight Co., Inc.、Merck & Co., Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Limited、The Cooper Companies, Inc.、The Female Health Company、Abviee Inc
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：プロゲスチン単独避妊薬、複合ホルモン避妊薬
・用途別分析2017年-2028年：病院、家庭、診療所
・避妊経皮パッチの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・避妊経皮パッチのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・避妊経皮パッチのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・避妊経皮パッチの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・避妊経皮パッチの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Contraceptive Transdermal Patche market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Contraceptive Transdermal Patche market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Contraceptive Transdermal Patche global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Progestin-only Contraceptive segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Contraceptive Transdermal Patche include Mylan Nv, Ansell Limited, Bayer AG, Church & Dwight Co., Inc., and Merck & Co., Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Contraceptive Transdermal Patche market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Progestin-only Contraceptive
Combined Hormonal Contraceptive
Market segment by Application can be divided into
Hospitals
Household
Clinics
The key market players for global Contraceptive Transdermal Patche market are listed below:
Mylan Nv
Ansell Limited
Bayer AG
Church & Dwight Co., Inc.
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Limited
The Cooper Companies, Inc.
The Female Health Company
Abviee Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contraceptive Transdermal Patche product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Contraceptive Transdermal Patche, with price, sales, revenue and global market share of Contraceptive Transdermal Patche from 2019 to 2022.
Chapter 3, the Contraceptive Transdermal Patche competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptive Transdermal Patche breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Contraceptive Transdermal Patche market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Contraceptive Transdermal Patche.
Chapter 13, 14, and 15, to describe Contraceptive Transdermal Patche sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Contraceptive Transdermal Patche Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Contraceptive Transdermal Patche Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Progestin-only Contraceptive
1.2.3 Combined Hormonal Contraceptive
1.3 Market Analysis by Application
1.3.1 Overview: Global Contraceptive Transdermal Patche Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Household
1.3.4 Clinics
1.4 Global Contraceptive Transdermal Patche Market Size & Forecast
1.4.1 Global Contraceptive Transdermal Patche Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Contraceptive Transdermal Patche Sales in Volume (2017-2028)
1.4.3 Global Contraceptive Transdermal Patche Price (2017-2028)
1.5 Global Contraceptive Transdermal Patche Production Capacity Analysis
1.5.1 Global Contraceptive Transdermal Patche Total Production Capacity (2017-2028)
1.5.2 Global Contraceptive Transdermal Patche Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Contraceptive Transdermal Patche Market Drivers
1.6.2 Contraceptive Transdermal Patche Market Restraints
1.6.3 Contraceptive Transdermal Patche Trends Analysis
2 Manufacturers Profiles
2.1 Mylan Nv
2.1.1 Mylan Nv Details
2.1.2 Mylan Nv Major Business
2.1.3 Mylan Nv Contraceptive Transdermal Patche Product and Services
2.1.4 Mylan Nv Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ansell Limited
2.2.1 Ansell Limited Details
2.2.2 Ansell Limited Major Business
2.2.3 Ansell Limited Contraceptive Transdermal Patche Product and Services
2.2.4 Ansell Limited Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Contraceptive Transdermal Patche Product and Services
2.3.4 Bayer AG Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Church & Dwight Co., Inc.
2.4.1 Church & Dwight Co., Inc. Details
2.4.2 Church & Dwight Co., Inc. Major Business
2.4.3 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product and Services
2.4.4 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck & Co., Inc.
2.5.1 Merck & Co., Inc. Details
2.5.2 Merck & Co., Inc. Major Business
2.5.3 Merck & Co., Inc. Contraceptive Transdermal Patche Product and Services
2.5.4 Merck & Co., Inc. Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer Inc.
2.6.1 Pfizer Inc. Details
2.6.2 Pfizer Inc. Major Business
2.6.3 Pfizer Inc. Contraceptive Transdermal Patche Product and Services
2.6.4 Pfizer Inc. Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Teva Pharmaceutical Industries Limited
2.7.1 Teva Pharmaceutical Industries Limited Details
2.7.2 Teva Pharmaceutical Industries Limited Major Business
2.7.3 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product and Services
2.7.4 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 The Cooper Companies, Inc.
2.8.1 The Cooper Companies, Inc. Details
2.8.2 The Cooper Companies, Inc. Major Business
2.8.3 The Cooper Companies, Inc. Contraceptive Transdermal Patche Product and Services
2.8.4 The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 The Female Health Company
2.9.1 The Female Health Company Details
2.9.2 The Female Health Company Major Business
2.9.3 The Female Health Company Contraceptive Transdermal Patche Product and Services
2.9.4 The Female Health Company Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Abviee Inc
2.10.1 Abviee Inc Details
2.10.2 Abviee Inc Major Business
2.10.3 Abviee Inc Contraceptive Transdermal Patche Product and Services
2.10.4 Abviee Inc Contraceptive Transdermal Patche Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Contraceptive Transdermal Patche Breakdown Data by Manufacturer
3.1 Global Contraceptive Transdermal Patche Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Contraceptive Transdermal Patche Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Contraceptive Transdermal Patche
3.4 Market Concentration Rate
3.4.1 Top 3 Contraceptive Transdermal Patche Manufacturer Market Share in 2021
3.4.2 Top 6 Contraceptive Transdermal Patche Manufacturer Market Share in 2021
3.5 Global Contraceptive Transdermal Patche Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Contraceptive Transdermal Patche Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Contraceptive Transdermal Patche Market Size by Region
4.1.1 Global Contraceptive Transdermal Patche Sales in Volume by Region (2017-2028)
4.1.2 Global Contraceptive Transdermal Patche Revenue by Region (2017-2028)
4.2 North America Contraceptive Transdermal Patche Revenue (2017-2028)
4.3 Europe Contraceptive Transdermal Patche Revenue (2017-2028)
4.4 Asia-Pacific Contraceptive Transdermal Patche Revenue (2017-2028)
4.5 South America Contraceptive Transdermal Patche Revenue (2017-2028)
4.6 Middle East and Africa Contraceptive Transdermal Patche Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Contraceptive Transdermal Patche Sales in Volume by Type (2017-2028)
5.2 Global Contraceptive Transdermal Patche Revenue by Type (2017-2028)
5.3 Global Contraceptive Transdermal Patche Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Contraceptive Transdermal Patche Sales in Volume by Application (2017-2028)
6.2 Global Contraceptive Transdermal Patche Revenue by Application (2017-2028)
6.3 Global Contraceptive Transdermal Patche Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Contraceptive Transdermal Patche Sales by Type (2017-2028)
7.2 North America Contraceptive Transdermal Patche Sales by Application (2017-2028)
7.3 North America Contraceptive Transdermal Patche Market Size by Country
7.3.1 North America Contraceptive Transdermal Patche Sales in Volume by Country (2017-2028)
7.3.2 North America Contraceptive Transdermal Patche Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Contraceptive Transdermal Patche Sales by Type (2017-2028)
8.2 Europe Contraceptive Transdermal Patche Sales by Application (2017-2028)
8.3 Europe Contraceptive Transdermal Patche Market Size by Country
8.3.1 Europe Contraceptive Transdermal Patche Sales in Volume by Country (2017-2028)
8.3.2 Europe Contraceptive Transdermal Patche Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Contraceptive Transdermal Patche Sales by Type (2017-2028)
9.2 Asia-Pacific Contraceptive Transdermal Patche Sales by Application (2017-2028)
9.3 Asia-Pacific Contraceptive Transdermal Patche Market Size by Region
9.3.1 Asia-Pacific Contraceptive Transdermal Patche Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Contraceptive Transdermal Patche Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Contraceptive Transdermal Patche Sales by Type (2017-2028)
10.2 South America Contraceptive Transdermal Patche Sales by Application (2017-2028)
10.3 South America Contraceptive Transdermal Patche Market Size by Country
10.3.1 South America Contraceptive Transdermal Patche Sales in Volume by Country (2017-2028)
10.3.2 South America Contraceptive Transdermal Patche Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Contraceptive Transdermal Patche Sales by Type (2017-2028)
11.2 Middle East & Africa Contraceptive Transdermal Patche Sales by Application (2017-2028)
11.3 Middle East & Africa Contraceptive Transdermal Patche Market Size by Country
11.3.1 Middle East & Africa Contraceptive Transdermal Patche Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Contraceptive Transdermal Patche Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Contraceptive Transdermal Patche and Key Manufacturers
12.2 Manufacturing Costs Percentage of Contraceptive Transdermal Patche
12.3 Contraceptive Transdermal Patche Production Process
12.4 Contraceptive Transdermal Patche Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Contraceptive Transdermal Patche Typical Distributors
13.3 Contraceptive Transdermal Patche Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 避妊経皮パッチの世界市場2022：プロゲスチン単独避妊薬、複合ホルモン避妊薬(Global Contraceptive Transdermal Patche Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

避妊経皮パッチの世界市場2022：プロゲスチン単独避妊薬、複合ホルモン避妊薬

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp